Artivion, Inc. (AORT) stock
AORTNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 11/305% below fair value
$18.54+0.27 (+1.48%)
Close on Nov 18, 2026Market cap $903.94MP/E –Yield –
Artivion revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Artivion's revenue for the twelve months ending Jun 30, 2026 was $471.47M, up 16.4% year over year. For fiscal 2025 it was $441.33M, up 13.6% from the year before. Over ten years it grew 11.7% a year on average. The highest annual figure on record is $441.33M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $441.33M | +13.6% |
| FY2024 | Dec 31, 2024 | $388.54M | +9.8% |
| FY2023 | Dec 31, 2023 | $354.00M | +12.8% |
| FY2022 | Dec 31, 2022 | $313.79M | +5.0% |
| FY2021 | Dec 31, 2021 | $298.84M | +18.0% |
| FY2020 | Dec 31, 2020 | $253.23M | -8.3% |
| FY2019 | Dec 31, 2019 | $276.22M | +5.1% |
| FY2018 | Dec 31, 2018 | $262.84M | +38.6% |
| FY2017 | Dec 31, 2017 | $189.70M | +5.2% |
| FY2016 | Dec 31, 2016 | $180.38M | +23.6% |
| FY2015 | Dec 31, 2015 | $145.90M | +0.9% |
| FY2014 | Dec 31, 2014 | $144.64M | +2.8% |
| FY2013 | Dec 31, 2013 | $140.76M | +6.9% |
| FY2012 | Dec 31, 2012 | $131.72M | +10.1% |
| FY2011 | Dec 31, 2011 | $119.63M | +2.6% |
| FY2010 | Dec 31, 2010 | $116.65M | +4.4% |
| FY2009 | Dec 31, 2009 | $111.69M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $125.76M | +11.3% |
| Q1 FY2026 | Mar 31, 2026 | $116.34M | +17.5% |
| Q4 FY2025 | Dec 31, 2025 | $115.99M | +19.2% |
| Q3 FY2025 | Sep 30, 2025 | $113.39M | +18.4% |
| Q2 FY2025 | Jun 30, 2025 | $112.97M | +15.3% |
| Q1 FY2025 | Mar 31, 2025 | $98.98M | +1.6% |
| Q4 FY2024 | Dec 31, 2024 | $97.31M | +3.9% |
| Q3 FY2024 | Sep 30, 2024 | $95.78M | +9.0% |
| Q2 FY2024 | Jun 30, 2024 | $98.02M | +9.8% |
| Q1 FY2024 | Mar 31, 2024 | $97.43M | +17.1% |
| Q4 FY2023 | Dec 31, 2023 | $93.67M | +18.0% |
| Q3 FY2023 | Sep 30, 2023 | $87.85M | +14.3% |
| Q2 FY2023 | Jun 30, 2023 | $89.25M | +11.1% |
| Q1 FY2023 | Mar 31, 2023 | $83.23M | +7.8% |
| Q4 FY2022 | Dec 31, 2022 | $79.40M | +0.0% |
| Q3 FY2022 | Sep 30, 2022 | $76.84M | +6.4% |
| Q2 FY2022 | Jun 30, 2022 | $80.34M | +5.5% |
| Q1 FY2022 | Mar 31, 2022 | $77.21M | +8.6% |
| Q4 FY2021 | Dec 31, 2021 | $79.39M | +16.9% |
| Q3 FY2021 | Sep 30, 2021 | $72.21M | +10.9% |
| Q2 FY2021 | Jun 30, 2021 | $76.15M | +41.6% |
| Q1 FY2021 | Mar 31, 2021 | $71.09M | +7.0% |
| Q4 FY2020 | Dec 31, 2020 | $67.90M | -2.6% |
| Q3 FY2020 | Sep 30, 2020 | $65.13M | -4.1% |
| Q2 FY2020 | Jun 30, 2020 | $53.77M | -24.4% |
| Q1 FY2020 | Mar 31, 2020 | $66.43M | -1.6% |
| Q4 FY2019 | Dec 31, 2019 | $69.70M | +2.8% |
| Q3 FY2019 | Sep 30, 2019 | $67.88M | +5.1% |
| Q2 FY2019 | Jun 30, 2019 | $71.14M | +3.9% |
| Q1 FY2019 | Mar 31, 2019 | $67.51M | +9.0% |
| Q4 FY2018 | Dec 31, 2018 | $67.80M | +28.3% |
| Q3 FY2018 | Sep 30, 2018 | $64.60M | +46.8% |
| Q2 FY2018 | Jun 30, 2018 | $68.50M | +43.2% |
| Q1 FY2018 | Mar 31, 2018 | $61.95M | +37.5% |
| Q4 FY2017 | Dec 31, 2017 | $52.83M | +17.3% |
| Q3 FY2017 | Sep 30, 2017 | $44.00M | -2.8% |
| Q2 FY2017 | Jun 30, 2017 | $47.82M | – |
| Q1 FY2017 | Mar 31, 2017 | $45.06M | – |
| Q4 FY2016 | Dec 31, 2016 | $45.03M | – |
| Q3 FY2016 | Sep 30, 2016 | $45.25M | – |
See a number that looks wrong?